Covered recipient · General Payments record
SARAH C NOBLE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$5,011.63
- Reported across 283 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $228.42 | 13 |
| Education | $56.45 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $58.58 | 3 |
| Teva Pharmaceuticals USA, Inc. | $56.45 | 1 |
| Janssen Pharmaceuticals, Inc | $52.16 | 3 |
| Supernus Pharmaceuticals, Inc. | $36.67 | 1 |
| Axsome Therapeutics, Inc. | $20.74 | 1 |
| Alkermes, Inc. | $20.63 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.20 | 1 |
| Corium, Inc. | $19.44 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.46 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105130167 | CMS |
| ABBVIE INC. | $18.96 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105130169 | CMS |
| ABBVIE INC. | $23.16 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105130171 | CMS |
| Alkermes, Inc. | $20.63 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120563674 | CMS |
| Axsome Therapeutics, Inc. | $20.74 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148319092 | CMS |
| Corium, LLC | $5.03 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100145243 | CMS |
| Corium, LLC | $8.25 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100151745 | CMS |
| Corium, LLC | $6.16 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100147297 | CMS |
| Janssen Pharmaceuticals, Inc | $24.01 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078157211 | CMS |
| Janssen Pharmaceuticals, Inc | $14.46 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078156989 | CMS |
| Janssen Pharmaceuticals, Inc | $13.69 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078156953 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.20 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118952348 | CMS |
| Supernus Pharmaceuticals, Inc. | $36.67 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147827361 | CMS |
| Teva Pharmaceuticals USA, Inc. | $56.45 | 06/20/2024 | Education | Undisputed | 01/23/2026 | 1151592395 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.